- Biden: US will share 60 million AstraZeneca vaccines to the world.
[Alles Europa News] ; It is no longer a news that the Biden administration have saved the United States from the chaos of an earlier covid-19 pandemic crisis that befell the country under the former President Trump.
Yes, the Biden administration has yet to announce how they will be shared or which countries will receive them.
The doses that the US government would donate would come from current vaccine stocks of Pfizer, Moderna or Johnson & Johnson, said the source, who requested anonymity before the official announcement.
President Joe Biden is expected to gives further that the United States will share an additional 20 million COVID-19 vaccines with the world over the next six weeks, a senior administration official noted earlier on the U.S media.
While AstraZeneca has been plagued by the blood clots reports issues, the world health organization has noted that the benefits on the long term on the general population , far superseded the general overall dangers.
AstraZeneca has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden and Gaithersburg in Maryland, U.S.
According to their wiki-pages, Since the merger it has been among the world’s largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014).
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993).
It is perhaps best known for its involvement in developing the Oxford-Astrazeneca COVID-19 vaccine.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
The doses would come from current vaccine stocks from Pfizer, Moderna or Johnson & Johnson, said the source, who asked to remain anonymous before the official announcement.
This is in addition to the Biden administration’s commitment to share some 60 million doses of the AstraZeneca vaccine by the end of June with other countries.